JP2023522725A5 - - Google Patents

Info

Publication number
JP2023522725A5
JP2023522725A5 JP2022564050A JP2022564050A JP2023522725A5 JP 2023522725 A5 JP2023522725 A5 JP 2023522725A5 JP 2022564050 A JP2022564050 A JP 2022564050A JP 2022564050 A JP2022564050 A JP 2022564050A JP 2023522725 A5 JP2023522725 A5 JP 2023522725A5
Authority
JP
Japan
Prior art keywords
isomer
pharmaceutically acceptable
methylazetidine
heptan
azabicyclo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022564050A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023522725A (ja
JP7618338B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/KR2021/004887 external-priority patent/WO2021215765A1/ko
Publication of JP2023522725A publication Critical patent/JP2023522725A/ja
Publication of JP2023522725A5 publication Critical patent/JP2023522725A5/ja
Application granted granted Critical
Publication of JP7618338B2 publication Critical patent/JP7618338B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022564050A 2020-04-20 2021-04-19 3-アザビシクロアルキル誘導体およびこれを含む薬剤学的組成物 Active JP7618338B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20200047190 2020-04-20
KR10-2020-0047190 2020-04-20
PCT/KR2021/004887 WO2021215765A1 (ko) 2020-04-20 2021-04-19 3-아자바이사이클로알킬 유도체 및 이를 포함하는 약제학적 조성물

Publications (3)

Publication Number Publication Date
JP2023522725A JP2023522725A (ja) 2023-05-31
JP2023522725A5 true JP2023522725A5 (cg-RX-API-DMAC7.html) 2024-04-26
JP7618338B2 JP7618338B2 (ja) 2025-01-21

Family

ID=78232792

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022564050A Active JP7618338B2 (ja) 2020-04-20 2021-04-19 3-アザビシクロアルキル誘導体およびこれを含む薬剤学的組成物

Country Status (7)

Country Link
US (1) US20230203008A1 (cg-RX-API-DMAC7.html)
EP (1) EP4134366A4 (cg-RX-API-DMAC7.html)
JP (1) JP7618338B2 (cg-RX-API-DMAC7.html)
KR (1) KR102614659B1 (cg-RX-API-DMAC7.html)
CN (1) CN115667244B (cg-RX-API-DMAC7.html)
TW (1) TWI810550B (cg-RX-API-DMAC7.html)
WO (1) WO2021215765A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021129737A1 (zh) 2019-12-24 2021-07-01 南京明德新药研发有限公司 具有khk抑制作用的化合物
WO2022022476A1 (zh) * 2020-07-28 2022-02-03 山东轩竹医药科技有限公司 己酮糖激酶抑制剂的盐、晶型及其用途
EP4269404A4 (en) * 2020-12-25 2024-12-04 Xizang Haisco Pharmaceutical Co., Ltd. KETOHEXOKINASE INHIBITORS AND USE THEREOF
JP2024544794A (ja) * 2021-12-24 2024-12-04 エルジー・ケム・リミテッド (s)-2-(2-メチルアゼチジン-1-イル)ピリミジン誘導体およびそれを含む医薬組成物
US20250145619A1 (en) * 2022-02-09 2025-05-08 Youngene Therapeutics Co., Ltd Khk inhibitor, preparation method therefor and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015359624B2 (en) * 2014-12-08 2020-01-02 Janssen Sciences Ireland Uc Piperidine substituted pyrazolo[1,5-a]pyrimidine derivatives with inhibitory activity on the replication of the respiratory syncytial virus (RSV)
TN2018000198A1 (en) * 2015-12-29 2019-10-04 Pfizer Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors
KR102558308B1 (ko) * 2018-09-27 2023-07-24 주식회사 엘지화학 3-아자바이사이클로[3,1,1]헵탄 유도체 및 이를 포함하는 약제학적 조성물
WO2020156445A1 (zh) * 2019-01-29 2020-08-06 山东轩竹医药科技有限公司 己酮糖激酶抑制剂及其用途
EP4269404A4 (en) * 2020-12-25 2024-12-04 Xizang Haisco Pharmaceutical Co., Ltd. KETOHEXOKINASE INHIBITORS AND USE THEREOF

Similar Documents

Publication Publication Date Title
TWI670270B (zh) 包含jak抑制劑之醫藥組合物
TWI526425B (zh) 二環性γ-胺基酸衍生物之製造中間體
TWI734134B (zh) 作為trk激酶抑制劑的大環化合物
JP6537527B2 (ja) Jak及びpi3k阻害剤併用によるb細胞悪性腫瘍の処置
EP2729448B1 (en) Compounds for the treatment of hiv
JP7222590B2 (ja) 3-アザビシクロ[3,1,1]ヘプタン誘導体及びこれを含む薬学的組成物
JP2025114615A (ja) 治療薬としての細胞毒素のペプチドコンジュゲート
CN113993590A (zh) 新型egfr抑制剂
JP4881725B2 (ja) Tie−2モジュレータと使用方法
CN105473573B (zh) 用作激酶抑制剂的咔唑甲酰胺化合物
EP2152712A1 (en) Amino-heterocyclic compounds
RU2010150799A (ru) НОВАЯ КРИСТАЛЛИЧЕСКАЯ И АМОРФНАЯ ФОРМА ТРИАЗОЛО(4,5-d)ПИРИМИДИНА
CN103214484A (zh) 作为两面神激酶抑制剂的杂芳基取代的吡咯并[2,3-b]吡啶和吡咯并[2,3-b]嘧啶
CN101863886A (zh) 用作生长激素促分泌素的杂环芳香化合物
CN102076650A (zh) 羧酸化合物
TW201249836A (en) 4-phenylamino-6-butenamide-7-alkyloxy quinazoline derivatives, preparative method and use thereof
JP7618338B2 (ja) 3-アザビシクロアルキル誘導体およびこれを含む薬剤学的組成物
TW200538112A (en) Novel compounds
WO2020007322A1 (zh) 一种靶向降解bet蛋白的化合物及其应用
CN105612162A (zh) 作为nmda受体活性的调节剂的噻唑并嘧啶酮类
JP6929857B2 (ja) 6,7,8,9−テトラヒドロ−5H−ピリド[2,3−d]アゼピンドーパミンD3リガンド
TW201827406A (zh) Nrf2活化劑
JP2023521237A (ja) 抗ウイルス1,3-ジ-オキソ-インデン化合物
JP2025527291A5 (cg-RX-API-DMAC7.html)
MX2010012540A (es) Derivados de imidazo[2,1-b]quinazolin-2-ona y su uso como agentes para inhibir la agregación plaquetaria.